Mechanistic Insights into Clinically Relevant Ribosome-Targeting Antibiotics
Biomolecules · 07.10.2024 · 14 (10) · 1263
DOI: 10.3390/biom14101263 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 07.10.2024. Verfasst von Szymon J Krawczyk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Poznan University of Medical Sciences, 60-781 Poznań, Poland. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Ribosomes. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre in Poland.
Abstract (Originalsprache)
Antibiotics targeting the bacterial ribosome are essential to combating bacterial infections. These antibiotics bind to various sites on the ribosome, inhibiting different stages of protein synthesis. This review provides a comprehensive overview of the mechanisms of action of clinically relevant antibiotics that target the bacterial ribosome, including macrolides, lincosamides, oxazolidinones, aminoglycosides, tetracyclines, and chloramphenicol. The structural and functional details of antibiotic interactions with ribosomal RNA, including specific binding sites, interactions with rRNA nucleotides, and their effects on translation processes, are discussed. Focus is placed on the diversity of these mechanisms and their clinical implications in treating bacterial infections, particularly in the context of emerging resistance. Understanding these mechanisms is crucial for developing novel therapeutic agents capable of overcoming bacterial resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Embryology, Poznan University of Medical Sciences, 60-781 Poznań, Poland.
- Department of Health Promotion, Poznan University of Medical Sciences, 60-781 Poznań, Poland.
- Department of Immunology, Poznan University of Medical Sciences, 60-806 Poznań, Poland.
ORCID-Profile: Ewelina Gowin
Förderung
- National Science Centre in Poland
Zitieren
APA
Krawczyk, S. J., Leśniczak-Staszak, M., Gowin, E., & Szaflarski, W. (2024). Mechanistic Insights into Clinically Relevant Ribosome-Targeting Antibiotics. Biomolecules, 14(10), 1263. https://doi.org/10.3390/biom14101263
Vancouver
Krawczyk SJ, Leśniczak-Staszak M, Gowin E, Szaflarski W. Mechanistic Insights into Clinically Relevant Ribosome-Targeting Antibiotics. Biomolecules. 2024;14(10):1263. doi:10.3390/biom14101263
BibTeX
@article{Krawczyk2024,
author = {Krawczyk, Szymon J and Leśniczak-Staszak, Marta and Gowin, Ewelina and Szaflarski, Witold},
title = {Mechanistic Insights into Clinically Relevant Ribosome-Targeting Antibiotics},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {10},
pages = {1263},
doi = {10.3390/biom14101263}
}
EUVIMED